Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Surveillance Snapshot: Human Papillomavirus Vaccination Among U.S. Active Component Service Members in the Millennium Cohort Study, 2006–2017

Image of HPV virus. HPV virus

The U.S. Millennium Cohort Study is a population-based prospective study that includes over 200,000 current and prior U.S. military service members.1,2

The cohort includes 4 panels of participants, the first of which was enrolled in 2001; subsequent panels were enrolled in 2004, 2007, and 2011. Questionnaires were sent to participants every 3 years to collect information on service-related experiences as well as mental, physical, and behavioral health. As such, the Millennium Cohort Study is uniquely positioned to leverage both administrative and self-reported data to help understand the effects of military service on the health of its members.

The analysis was restricted to active component members under age 26 in 2006 (women) or 2009 (men). The primary outcomes were human papillomavirus (HPV) vaccine initiation, completion (3 doses), and adherence (3 doses within 1 year). Medical encounter and central immunization databases were used to identify those who had received the HPV vaccine through June 2017. The analysis sample included 22,387 female and 31,705 male Millennium Cohort Study participants.

Overall, among service women in the analysis sample, 37.8% initiated the HPV vaccine and 40.2% of initiators were adherent (Figure 1). Among service men in the analysis sample, 3.9% initiated the vaccine and 23.1% of initiators were adherent (Figure 2). Compared to their respective counterparts, members of the Air Force and those in health care occupations had higher percentages of initiation and adherence. Initiation and adherence percentages were lower among self-reported ever smokers (cigarette) compared to never smokers. No differences were observed for other selected measures such as depression, panic or anxiety, or problem drinking (data not shown).

Author affiliations: Deployment Health Research Department in the Military Population Health Directorate, Naval Health Research Center, San Diego, CA (Dr. Matsuno, Dr. Porter, Mr. Warner, CDR Wells); Leidos, Inc., San Diego, CA (Dr. Matsuno, Dr. Porter, Mr. Warner)

Disclaimer: The authors are military service members or employees of the U.S. Government, or contract employees of the Government. This work was prepared as part of their official duties. Title 17, U.S.C. §105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C. §101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.

This work was supported by the Military Operational Medicine Research Program under work unit no. 60002. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government.

The study protocol was approved by the Naval Health Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center, Institutional Review Board protocol number NHRC.2000.0007.

References

  1. Gray GC, Chesbrough KB, Ryan MA, et al. The Millennium Cohort Study: a 21-year prospective cohort study of 140,000 military personnel. Mil Med. 2002;167(6):483–488.
  2. Ryan MA, Smith TC, Smith B, et al. Millennium Cohort: enrollment begins a 21-year contribution to understanding the impact of military service. J Clin Epidemiol. 2007;60(2):181–191.

 

Percentages of all eligible service women (n=22,387) who initiated (n=8,453), completed (n=5,179), and adhered (n=3,400) to guidelines for HPV vaccination, active component, U.S. Armed Forces, 2006–2017

Percentages of all eligible service men (n=31,705) who initiated (n=1,231), completed (n=429), and adhered (n=272) to guidelines for HPV vaccination, active component, U.S. Armed Forces, 2009–2017

You also may be interested in...

Article
Jan 1, 2024

Brief Report: The Four Most Frequently Diagnosed Vector-borne Diseases Among Service Member and Non-Service Member Beneficiaries in the Geographic Combatant Commands, 2010–2022

This report provides linear trends of selected vector-borne diseases, over a 13-year surveillance period, among Armed Forces service and non-service member beneficiaries diagnosed at installations within the Northern Command (NORTHCOM), Africa Command (AFRICOM), Central Command (CENTCOM), European Command (EUCOM), Indo-Pacific Command (INDOPACOM), or ...

Article
Jan 1, 2024

Ivermectin Prescription Fill Rates Among U.S. Military Members During the Coronavirus Disease 2019 (COVID-19) Pandemic

This report describes ivermectin prescription fill rates among U.S. active component service members over time during the early phases of the COVID-19 pandemic. Ivermectin prescription fill rates increased among active component service members early in the COVID-19 pandemic when misinformation about the effectiveness of ivermectin for prevention and ...

Article
Jan 1, 2024

Reportable Medical Events at Military Health System Facilities Through Week 48, Ending November 30, 2023

Each month the MSMR publishes an update of reportable medical events documented in the Disease Reporting System internet by health care providers and public health officials throughout the Military Health System, for monitoring, controlling, and preventing the occurrence and spread of diseases of public health interest or readiness importance.

Article
Dec 1, 2023

Reportable Medical Events at Military Health System Facilities Through Week 44, Ending November 4, 2023

Chlamydia, by far the most frequently reported medical event (RME) with the MHS, declined by 17% in October, to 1,190 cases, from 1,437 cases (adjusted) in September; this follows a 15% decline from August to September. Gonorrhea, the second highest RME, declined 15% in October, to 192 cases reported cases in September, from 225 cases (adjusted). ...

Skip subpage navigation
Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery